Business
Latest Headlines
Top Stories
Breaking News
Earnings
Biotech
Investors
Stock Alerts
IPOs
M&A
Canadian
UK
Wallstreet Events
- Industry News
- Technology
- Software
- Banking
- Automotive
- Energy
- More
- Drug Approvals
- Clinical Trial Calendar

Economic News
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard

Crypto
Cryptocurrency
Blockchain

Markets
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies

Politics
US
World
White House
Elections
General News

Forex
FX Top Stories
Currency Analysis
Currency Alerts
Economic Calendar
Economic Scorecard

Health
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health

Slide Shows

Entertainment
Top Stories
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre

Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services

Premium
Intelligent Investor
Biotech Investor NEW
Login

Latest News Videos
Free Content
RSS Feeds
Press Releases
Search
Contact Us

Business
Corp. News
- Latest Headlines
- Biotech
- Investors
- Stock Alerts
- IPOs
- M&A
Industry News
- Technology
- Software
- Banking
- Automotive
- Energy
- More
Corp. Calendars
Earnings Calendar
FDA Calendars
- Drug Approvals
- Clinical Trial Calendar
Ratings Changes
Economy
- US
- Europe
- Asia
- Global
- Economic Calendar
- Economic Scorecard
Crypto
- Cryptocurrency
- Blockchain
Markets
Market News
Politics
- US
- World
- White House
- Elections
- General News
Forex
Health
Health News
Slide Shows
Entertainment
Entertainment News
- Top Stories
Music News
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre
Content Licensing
Premium
More

Teva Pharmaceutical Industries Limited (TEVA)

Weekly Buzz: FDA Okays Saphnelo Pen, EC Clears Acromegaly Drug, SNGX Slumps, LGND Snaps Up XOMA 4/30/2026 9:47:31 AM

Teva Lowers 2026 Non-GAAP Operating Profit Outlook On Emalex Deal; On Track To Achieve 2027 Targets 4/29/2026 8:08:32 AM

Teva Acquires Emalex Biosciences, Expands Neuroscience Pipeline 4/29/2026 7:28:41 AM

Teva Pharmaceutical Industries Limited Q1 Income Rises 4/29/2026 7:22:41 AM

Teva Q1 Attributable Net Income Rises To $369 Mln Or $0.31/shr From $214 Mln Or $0.18/shr Last Year 4/29/2026 7:06:05 AM

Teva To Acquire Emalex Biosciences For $700 Mln Upfront 4/29/2026 6:58:04 AM

Teva Pharma Agrees To Buy Emalex Biosciences For $700 Mln Cash 4/29/2026 6:34:42 AM

Teva Pharma Launches Online Home Ground Schizophrenia Community 4/15/2026 8:07:34 AM

Weekly Buzz: SPRY Gains FDA Nod; EU Expands Kerendia Label; LLY Acquires CNTA; BIIB Snaps Up APLS 4/3/2026 5:10:06 AM

Teva Secures FDA Nod For PONLIMSI, Biosimilar Candidate To Xolair Applications Accepted By FDA & EMA 3/30/2026 9:29:13 AM

Teva Secures FDA Approval For PONLIMSI And Advances Biosimilar Applications For Xolair In U.S. And EU 3/30/2026 8:09:41 AM

Leerink Partners Global Biopharma Conference 2026: TEVA, CYTK, IMRX, TNYA And More Set To Present 3/8/2026 10:21:10 AM

Teva: Blackstone Life Sciences To Provide $400 Mln To Support Development Of Duvakitug 3/4/2026 1:11:03 AM

Teva Pharma And Blackstone Life Sciences Announces $400 Mln Strategic Funding Agreement 3/3/2026 5:04:46 PM

FDA Accepts NDA For Teva And Medincell's Olanzapine LAI In Schizophrenia Treatment 2/21/2026 1:31:14 AM

Weekly Buzz: NRXP Sets The Path For NRX-100's NDA; IRON Gets FDA's CRL; TOVX Licenses SYN-020 2/20/2026 9:27:44 AM

Sanofi And Teva Announce Positive Results From RELIEVE UCCD Long-term Extension Study 2/17/2026 8:30:04 AM

Teva, Sanofi's Phase 2b Trial Of Duvakitug Shows Durable Efficacy In UC & Crohn's 2/17/2026 7:47:27 AM

Older Articles

Copyright © 2026 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us | Contact Us | Privacy | Sitemap